Inflammatory Responses Completed Phase 3 Trials for Sodium chloride (DB09153)

Also known as: Inflammatory Response

IndicationStatusPhase
DBCOND0062877 (Inflammatory Responses)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs